5-(2-Chloro-10H-phenothiazin-10-yl)pentanamide

ID: ALA5177125

Chembl Id: CHEMBL5177125

PubChem CID: 168274996

Max Phase: Preclinical

Molecular Formula: C17H17ClN2OS

Molecular Weight: 332.86

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)CCCCN1c2ccccc2Sc2ccc(Cl)cc21

Standard InChI:  InChI=1S/C17H17ClN2OS/c18-12-8-9-16-14(11-12)20(10-4-3-7-17(19)21)13-5-1-2-6-15(13)22-16/h1-2,5-6,8-9,11H,3-4,7,10H2,(H2,19,21)

Standard InChI Key:  ZWWUAKRPUMYAAD-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5177125

    ---

Associated Targets(Human)

PSMB2 Tclin 20S proteasome (530 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 332.86Molecular Weight (Monoisotopic): 332.0750AlogP: 4.60#Rotatable Bonds: 5
Polar Surface Area: 46.33Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.10CX LogD: 4.10
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.81Np Likeness Score: -1.29

References

1. Staerz SD, Jones CL, Tepe JJ..  (2022)  Design, Synthesis, and Biological Evaluation of Potent 20S Proteasome Activators for the Potential Treatment of α-Synucleinopathies.,  65  (9.0): [PMID:35476454] [10.1021/acs.jmedchem.1c02158]

Source